# Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation

> **NCT00139009** · PHASE4 · COMPLETED · sponsor: **University of Oslo School of Pharmacy** · enrollment: 30 (—)

## Conditions studied

- Renal Transplantation
- Heart Transplantation

## Interventions

- **DRUG:** Cyclosporine A

## Key facts

- **NCT ID:** NCT00139009
- **Lead sponsor:** University of Oslo School of Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139009, "Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00139009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*